Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MITO Long-term Study of SPP-004 in Mitochondrial Diseases
jRCT2091220406Completed
- Sponsor
- Saitama Medical University Hospital
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of 5-aminolevulinic acid hydrochloride + sodium ferrous citrate in Mitochondriopathy, sponsored by Saitama Medical University Hospital. Primary endpoint: Safety. Started Jan 2019; status: completed.
02
Drugs
5-aminolevulinic acid hydrochloride + sodium ferrous citrate
03
Conditions
Mitochondriopathy
Beyond the preview
Go deeper on jRCT2091220406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2091220406.